First Citizens Bank & Trust’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,530
Closed -$325K 350
2023
Q2
$325K Sell
2,530
-72
-3% -$8.71K 0.01% 287
2023
Q1
$302K Buy
2,602
+274
+12% +$30.7K 0.01% 278
2022
Q4
$264K Buy
+2,328
New +$256K 0.01% 281

Other funds holding DXCM

First Citizens Bank & Trust's DXCM Position: Q3 2023 in Review

First Citizens Bank & Trust sold out of DexCom (DXCM) in Q3 2023, closing a stake of 2,530 shares — an estimated $325K sold.

First Citizens Bank & Trust first reported a position in DXCM in Q4 2022 and held it in 3 quarters. The position peaked at $325K in Q2 2023. 903 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • First Citizens Bank & Trust reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • First Citizens Bank & Trust sold 2,530 DexCom shares in Q3 2023, an estimated $325K.
  • First Citizens Bank & Trust first reported a position in DexCom in Q4 2022 and held it in 3 quarters.
  • First Citizens Bank & Trust's DexCom position peaked at $325K in Q2 2023.
  • 903 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on First Citizens Bank & Trust's 13F filing for Q3 2023, filed 30 Oct 2023.